FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * BROENNIMAN EDWARD G   2. Issuer Name and Ticker or Trading Symbol AETHLON MEDICAL INC [AEMD.OB] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 8910 UNIVERSITY CENTER LANE, #660 3. Date of Earliest Transaction (Month/Day/Year) 03/15/2010 (Street) SAN DIEGO, CA 92122 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/15/2010 03/18/2010 S   6,700 (1) D $ 0.38 475,474 (2) D   Common Stock 03/16/2010 03/19/2010 S   7,000 (1) D $ 0.39 468,474 (2) D   Common Stock 03/17/2010 03/22/2010 S   7,100 (1) D $ 0.407 461,374 (2) D   Common Stock 03/18/2010 03/23/2010 S   7,200 (1) D $ 0.38 454,174 (2) D   Common Stock 03/19/2010 03/24/2010 S   7,400 (1) D $ 0.39 446,774 (2) D   Common Stock 03/22/2010 03/25/2010 S   7,700 (1) D $ 0.385 439,074 (2) D   Common Stock 03/23/2010 03/26/2010 S   7,700 (1) D $ 0.39 431,374 (2) D   Common Stock 03/24/2010 03/29/2010 S   8,000 (1) D $ 0.39 423,374 (2) D   Common Stock 03/25/2010 03/30/2010 S   9,000 (1) D $ 0.45 414,374 (2) D   Common Stock 03/26/2010 03/31/2010 S   10,000 (1) D $ 0.41 404,374 (2) D   Common Stock 03/29/2010 04/01/2010 S   11,000 (1) D $ 0.39 393,374 (2) D   Common Stock 03/30/2010 04/02/2010 S   11,000 (1) D $ 0.38 382,374 (2) (3) D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
BROENNIMAN EDWARD G 8910 UNIVERSITY CENTER LANE, #660 SAN DIEGO, CA 92122	X

Signatures

/s/ Edward G. Broenniman		04/02/2010
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The shares of common stock were sold by Mr. Broenniman pursuant to a 10b5-1 selling plan providing for the sale of up to 200,000 shares of the issuer's common stock between March 15, 2010 and March 14, 2011. The plan provides for sales of the shares at a price of no less than $0.30 per share, at a rate of no more than 5% of the average trading volume in the issuer's common stock for the 30-day period preceding the sale, as reported on dailyfinance.com; provided that such sales may not exceed 1% of the outstanding share balance during any 90-day period.
(2)	In addition to the currently outstanding shares of common stock owned by Mr. Broenniman and reported here, Mr. Broenniman also beneficially owns the shares of common stock underlying the following stock options: options to purchase 2,500 shares of common stock at $3.75 per share; options to purchase 3,000 shares of common stock at $1.78 per share; options to purchase 514,550 shares of common stock at $0.38 per share; and options to purchase 500,000 shares of common stock at $0.41 per share.
(3)	Includes 33,885 shares of common stock owned by Linda Broenniman, the spouse of Edward Broenniman, and 346,500 shares jointly owned by Edward and Linda Broenniman.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.